17-48550776-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001384749.1(HOXB3):c.854G>A(p.Ser285Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000303 in 1,605,196 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001384749.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HOXB3 | NM_001384749.1 | c.854G>A | p.Ser285Asn | missense_variant | 5/5 | ENST00000498678.6 | NP_001371678.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HOXB3 | ENST00000498678.6 | c.854G>A | p.Ser285Asn | missense_variant | 5/5 | 2 | NM_001384749.1 | ENSP00000420595.1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152032Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000274 AC: 68AN: 248220Hom.: 0 AF XY: 0.000276 AC XY: 37AN XY: 134236
GnomAD4 exome AF: 0.000314 AC: 457AN: 1453164Hom.: 0 Cov.: 32 AF XY: 0.000304 AC XY: 219AN XY: 721346
GnomAD4 genome AF: 0.000197 AC: 30AN: 152032Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74258
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.854G>A (p.S285N) alteration is located in exon 4 (coding exon 2) of the HOXB3 gene. This alteration results from a G to A substitution at nucleotide position 854, causing the serine (S) at amino acid position 285 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at